Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
PENNSYLVANIA
Johnson & Johnson Agrees to Fraud Resolution
On Nov. 4, the DOJ announced that it had reached an agreement with pharmaceutical manufacturer Johnson & Johnson (J&J) and its subsidiaries to resolve multiple health care fraud investigations (state and federal) relating to Invenga, Natrecor, and Risperdal, prescription drugs manufactured by the company. In a combination of civil and criminal actions across three states, J&J was accused of promoting the three prescription drugs for uses not approved as safe and effective by the Food and Drug Administration (FDA) pursuant to the requirements of the federal Food, Drug, and Cosmetic Act (FDCA), as well as paying kickbacks to doctors in connection with prescriptions for the same.
The financial component of the settlement, characterized by the DOJ as “one of the largest health care fraud settlements in U.S. history,” requires J&J to pay more than $2.2 billion. Beyond the monetary impact, J&J also agreed to a five-year Corporate Integrity Agreement (CIA) with the Office of Inspector General of the Department of Health and Human Services (HHS-OIG).
PENNSYLVANIA
On Nov. 4, the DOJ announced that it had reached an agreement with pharmaceutical manufacturer
The financial component of the settlement, characterized by the DOJ as “one of the largest health care fraud settlements in U.S. history,” requires J&J to pay more than $2.2 billion. Beyond the monetary impact, J&J also agreed to a five-year Corporate Integrity Agreement (CIA) with the Office of Inspector General of the Department of Health and Human Services (HHS-OIG).
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
During the COVID-19 pandemic, some tenants were able to negotiate termination agreements with their landlords. But even though a landlord may agree to terminate a lease to regain control of a defaulting tenant's space without costly and lengthy litigation, typically a defaulting tenant that otherwise has no contractual right to terminate its lease will be in a much weaker bargaining position with respect to the conditions for termination.
What Law Firms Need to Know Before Trusting AI Systems with Confidential Information In a profession where confidentiality is paramount, failing to address AI security concerns could have disastrous consequences. It is vital that law firms and those in related industries ask the right questions about AI security to protect their clients and their reputation.
The International Trade Commission is empowered to block the importation into the United States of products that infringe U.S. intellectual property rights, In the past, the ITC generally instituted investigations without questioning the importation allegations in the complaint, however in several recent cases, the ITC declined to institute an investigation as to certain proposed respondents due to inadequate pleading of importation.
As the relationship between in-house and outside counsel continues to evolve, lawyers must continue to foster a client-first mindset, offer business-focused solutions, and embrace technology that helps deliver work faster and more efficiently.
Practical strategies to explore doing business with friends and social contacts in a way that respects relationships and maximizes opportunities.